⌘K

Login Start Free

Home/Filings/4/0001493152-25-016957

4//SEC Filing

Aminov Erez 4

Accession 0001493152-25-016957

CIK 0001904286other

View on SEC.gov Company Profile

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 8:00 PM ET

Size

5.0 KB

Accession

0001493152-25-016957

Insider Transaction Report

Form 4

Period: 2025-10-01

MIRA PHARMACEUTICALS, INC.MIRA

DirectorChief Executive Officer

Transactions

Award
Common Stock
2025-10-01+2,685,456→ 3,530,156 total

Footnotes (1)

[F1]Represents 2,685,456 restricted shares of common stock, par value $0.0001 of the Issuer issued as compensation for the Issuer's acquisition of SKNY Pharmaceuticals, Inc.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

MIRA PHARMACEUTICALS, INC.

CIK 0001904286

Entity typeother

Related Parties

1

filerCIK 0001986112

Filing Metadata

Form type: 4
Filed: Oct 2, 8:00 PM ET
Accepted: Oct 3, 8:00 PM ET
Size: 5.0 KB

View on SEC.gov